MRI contrast developer Epix Pharmaceuticals reported that Peyton Marshall, its chief financial officer and senior vice president of finance and administration, has resigned his position to pursue other interests.
Epix also announced the promotion of Robert Pelletier, currently the company's senior director of finance, to the position of principal accounting officer and executive director of finance, according to the Cambridge, MA-based firm.
By AuntMinnie.com staff writers
July 6, 2005
Related Reading
Epix's Vasovist moves closer to market, July 1, 2005
Epix submits response to FDA, May 23, 2005
Epix revenues, income down in Q1, April 29, 2005
Epix launches blood-clot agent trial, April 7, 2005
Epix signs DeWitt, April 5, 2005
Copyright © 2005 AuntMinnie.com
